Marion Barbazanges

ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment

Hetal Patel, Manikandan Periyasamy, Georgina P. Sava et al. · Molecular Cancer Therapeutics · 2018 · 138 citations · Full text

A Novel Pyrazolo[1,5-<i>a</i>]pyrimidine Is a Potent Inhibitor of Cyclin-Dependent Protein Kinases 1, 2, and 9, Which Demonstrates Antitumor Effects in Human Tumor Xenografts Following Oral Administration

Dean A. Heathcote, Hetal Patel, Sebastian H. B. Kroll et al. · Journal of Medicinal Chemistry · 2010 · 99 citations · Full text

Enantioselective Ir^I‐Catalyzed Carbocyclization of 1,6‐Enynes by the Chiral Counterion Strategy

Marion Barbazanges, Mylène Augé, Jamal Moussa et al. · Chemistry - A European Journal · 2011 · 87 citations

Double-Stereodifferentiation in Rhodium-Catalyzed [2 + 2 + 2] Cycloaddition: Chiral Ligand/Chiral Counterion Matched Pair

Mylène Augé, Alexandra Feraldi‐Xypolia, Marion Barbazanges et al. · Organic Letters · 2015 · 53 citations

Chemical Engineering, Engineering, Double Asymmetric Induction +9

Stereoselective Synthesis of 1,2-Aminoalcohols by [2,3]-Wittig Rearrangements

Marion Barbazanges, Christophe Meyer, Janine Cossy · Organic Letters · 2007 · 47 citations

Alcohol Derivatives, Engineering, Anti Diastereoselectivity +8